One recurring theme was St. Louis’ pool of scientific talent—not only at large companies such as Bayer (formerly Monsanto) but also in the constellation of smaller, newer ones. “If a startup struggles and has to go through reductions or shut-downs, we’re now mature enough to where other startups can pick them up,” says Martha Schlicher, CEO of Impetus Ag and a general partner at the venture capital firm Cultivation Capital…
